论文部分内容阅读
为了解恶性风险指数(RMI)对区别良或恶性盆腔包块的意义,并为比较3种RMI(1,2,3)进行一项研究。 1997年1月～1999年8月间,152例盆腔包块患者接受腹腔镜或剖腹探查术。收集术前血清CA125值、超声检查、月经情况的资料。经腹或阴道超声如有下列表现则提示恶性:多房囊肿、实性区域、双侧病变、腹水、腹腔内转移。每项记1分,计算每例患者的超声总分(U)。绝经定为闭经>1年或>50岁的切除子宫者。血清标本均术前采集,根据产品介绍的方法,用微粒酶免疫测定CA125水平,敏感性为2U/ml。①RMI1=U×M×CA125,超声记分0:U=0;记分1:U=1;记分≥2:U=3。未绝经M=1,绝经M=3。CA125直接用测定值。②RMI2=U×M×CA125,超声记分0或1:U=1;记分≥2:U=4。未绝
To understand the significance of the malignant risk index (RMI) for distinguishing between benign and malignant pelvic masses, a study was conducted comparing three RMIs (1, 2, 3). From January 1997 to August 1999, 152 patients with pelvic mass underwent laparoscopic or laparotomy. Preoperative serum CA125 values, ultrasound examination, menstrual situation information. Transabdominal or vaginal ultrasound if the following performance tips malignant: multiple cysts, solid regions, bilateral lesions, ascites, intraperitoneal metastasis. Score 1 for each item and calculate the total ultrasound score (U) for each patient. Menopause Menopause> 1 year or> 50 years of the uterus. Serum samples were collected preoperatively, according to the method of introduction of the product, the level of CA125 was measured by the enzyme-linked immunosorbent assay (MIC), the sensitivity was 2U / ml. ① RMI1 = U × M × CA125, ultrasonic score 0: U = 0; score 1: U = 1; score ≥ 2: U = 3. Not menopausal M = 1, menopause M = 3. CA125 direct use of the measured value. ② RMI2 = U × M × CA125, ultrasound score 0 or 1: U = 1; score ≥ 2: U = 4. Not yet